-
Man allegedly behind 'targeted' attack on Australian lawmaker appears in court
-
Man allegedly behind 'targeted' attack on Australian lawmaker due in court
-
Musk backs SpaceX-Tesla merger as rocket firm turns profit
-
Netflix shares drop on slowing engagement, revenue growth
-
Zelensky, US hail 'productive' talks to end Trump feud
-
Rodri needed a rest for Barcelona ahead of Clasico, says Flick
-
'Unbelievable' Foden back in the groove with treble in Man City rout
-
Musk says backs SpaceX-Tesla merger as rocket firm turns profit
-
Pistons rally to beat Celtics in NBA 2026-27 season opener
-
US regulators certify Boeing 737 MAX 10 after delays
-
PSG late show downs Barca in Champions League, Liverpool fight back
-
PSG strike late to get better of Yamal and Barcelona in Champions League
-
Liverpool strike back to beat Villarreal in seven-goal thriller
-
Foden hat-trick fuels Man City rout of AEK Athens
-
Dow boosted as markets rotate from tech shares
-
Trump says he wants Zelensky to 'make a deal' with Russia
-
Zelensky hails resumption of US advance warning of strikes on Ukraine
-
'I want it so badly': PSG heartbreak fuelling Arsenal, says Arteta
-
Carrick says only wins can ease doubts over Man Utd future
-
Lula campaign seeks to disqualify Bolsonaro over Meta 'interference'
-
Top NBA Draft pick Dybantsa to miss opener with ankle sprain
-
All who profited from fund scandal 'identified': Turkish minister
-
Italy sends troops, toughens security laws after Milan clashes
-
Christina Applegate says she was misdiagnosed with MS
-
Alberta separatists vow to fight on, risking turmoil for Canada
-
Ronaldo let Man Utd down says Ten Hag
-
Two men re-arrested for suspected spying for Iran in airbase scare: UK police
-
Meta says it complied with Brazil court order to treat candidates equally
-
Guatemalan man gets 30 years for truck smuggling deaths of 53 migrants
-
Inequality is major factor in impact of non-communicable diseases : WHO
-
'Clayface' gets under the skin of the superhero genre
-
Italy to send 500 troops to Milan after clashes
-
Zelensky, US envoys hold Oslo talks as Ukraine claims US missile holdup
-
BBC slashes 100 jobs, closes two channels
-
All-rounder Minhas stars as Pakistan crush England in tri-series
-
Tech jitters lead stocks lower, oil surges then slides
-
Bavuma hits 179, Rabada strikes as South Africa dominate
-
Wild West Wing? Turmoil revives memories of Trump 1.0
-
Allrounder Minhas stars as Pakistan crush England in tri-series
-
Tap water no longer drinkable near South Africa capital
-
Albania PM blames 'hybrid war' for week of unrest
-
Arsenal coach Arteta always a leader, says former teammate Gnabry
-
Bavuma hits 179 to lead South African fightback
-
Investors pledge 230 billion euros at German summit: Merz
-
Solid GM results overshadowed by latest jump in commodity costs
-
Emery adamant injuries 'no excuse' for Aston Villa
-
Houthi attacks undermine Saudi Arabia's economic ambitions
-
UN demands aid access to besieged Yemen city Taiz
-
French PM vows 'massive' police deployment for new demonstrations
-
Faletau still in Tandy's plans despite being left out of Wales squad
Laser Photonics Receives $1.3 Million Order for Pharmaceutical Tablet Laser Drilling System
Significant Order with New International Pharmaceutical Customer Highlights Company's Growth and Revenue Opportunity
ORLANDO, FLORIDA / ACCESS Newswire / January 22, 2026 / Laser Photonics Corporation (NASDAQ:LASE), a global leader in laser systems for industrial and defense applications, today announced that it has received a $1.3 million order for a CMS Laser Pharmaceutical Tablet Laser Drilling System from a new international pharmaceutical customer.
Laser Photonics' subsidiary CMS Laser engineers fully automated, laser-powered tablet drilling systems for full-scale, high-volume pharmaceutical manufacturing. The new order is for a custom TD-140, designed for single-sided drilling of up to 140,000 circular tablets per hour. The system combines advanced CO2 laser hardware, dual-vision inspection, and an oscilloscope for remote diagnostics to meet the most demanding commercial production environments. CMS Laser's solutions for the medical and pharmaceutical industries incorporate software designed to help customers meet FDA 21 CFR Part 11 requirements related to electronic signatures and audit logs.
Wayne Tupuola, the Chief Executive Officer of Laser Photonics, commented: "This significant order from a new customer will meet demanding production requirements, highlighting our system's precision, reliability, and validation standards in highly regulated manufacturing. CMS Laser provides advanced solutions to pharmaceutical companies around the world, addressing a wide range of pharmaceutical needs, from high-volume tablet drilling and marking to research and development.
"We are accelerating our market position in the high-demand pharmaceutical equipment sector known for its growth and stability, securing new and repeat orders for high-precision applications worldwide. Robust demand and a pipeline of new opportunities are rapidly building momentum for us as we expand our sales and marketing infrastructure, customer engagement, and market reach. We believe we will continue to strengthen revenue and growth in the months to come as we strive to build sustainable shareholder value over the long term."
To learn more about CMS Laser's tablet drilling technology, please visit our blog.
About Laser Photonics Corporation
Laser Photonics Corporation (NASDAQ:LASE) is a global leader in laser systems for industrial and defense applications. The Company develops and manufactures advanced laser technologies used in cleaning, surface preparation, and precision material processing across demanding operating environments. Laser Photonics serves a broad range of end markets, including defense and government, aerospace, energy, maritime, automotive, and advanced manufacturing. Through a combination of internal development, strategic acquisitions, and partnerships, the Company continues to expand its product portfolio and address new applications where performance, efficiency, and environmental considerations are critical. For more information, please visit laserphotonics.com.
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. These statements are based on current expectations as of the date of this press release and involve risks and uncertainties that may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. We encourage readers to review the "Risk Factors" in our Registration Statement for a comprehensive understanding. Laser Photonics Corp. undertakes no obligation to revise or update any forward-looking statements, except as required by applicable laws or regulations, to reflect events or circumstances after the date of this press release.
Investor Relations Contact
Lucas A. Zimmerman & Ian Scargill
MZ Group - MZ North America
(262) 357-2918
[email protected]
www.mzgroup.us
SOURCE: Laser Photonics Corp.
View the original press release on ACCESS Newswire
T.Sanchez--AT